Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Relative Bioavailability Study in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway
- Status
- TERMINATED
- Phase
- N/A
Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVR
- Status
- UNKNOWN
- Phase
- N/A
Advair Pediatric Once-Daily
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
GSK BHR Study (Sont)
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers
- Status
- COMPLETED
- Phase
- PHASE3
Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)
- Status
- COMPLETED
- Phase
- PHASE2
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
- Status
- COMPLETED
- Phase
- PHASE3
The Canadian Cohort Obstructive Lung Disease
- Status
- UNKNOWN
- Phase
- N/A
DDI Study of Etravirine and GSK1265744
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795
- Status
- COMPLETED
- Phase
- PHASE1
Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
- Status
- COMPLETED
- Phase
- PHASE2
Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
- Status
- COMPLETED
- Phase
- PHASE1
Cognitive Effects of Treatment of Interictal Discharges
- Status
- COMPLETED
- Phase
- NA